OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

TERUMO CORP./  JP3546800008  /

Frankfurt
2024-08-30  8:05:23 AM Chg. -0.4000 Volume Bid9:50:29 PM Ask9:50:29 PM Market Capitalization Dividend Y. P/E Ratio
16.5000EUR -2.37% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 24.76 bill.EUR - -
GlobeNewswire 08-12 Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 07-30 Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board o...
GlobeNewswire 07-10 Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company
GlobeNewswire 06-10 Over 80 Organizations Kick Off Blood Advocacy Week by Urging Congress to Support the Blood Supply as...
GlobeNewswire 06-04 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...
GlobeNewswire 05-22 Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
GlobeNewswire 05-13 Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 05-09 R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire 04-30 Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire 04-30 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire 04-02 Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
GlobeNewswire 03-26 Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire 03-13 Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire 03-07 Orchestra BioMed to Participate in Upcoming Investor Conferences
GlobeNewswire 03-06 Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire 02-26 Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire 02-20 TransPerfect’s GlobalLink/Adobe Experience Manager (AEM) Integration Adds 30+ Global Brands in 2023
GlobeNewswire 01-08 Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire 2023-11-13 Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 2023-11-09 Orchestra BioMed to Present at Upcoming Investor Conferences
GlobeNewswire 2023-09-19 Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for...
GlobeNewswire 2023-08-24 NeurAxis Highlights Strength of its Board of Directors
GlobeNewswire 2022-02-03 Applied Science, Inc. Announces New Vice President of Sales, Marketing & Customer Care, Ral Trujillo
GlobeNewswire 2021-12-17 Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapie...
GlobeNewswire 2021-11-18 Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expa...